Yingyi Wang

Yingyi Wang

Auto-generated profile, based on publicly available information

Yingyi Wang

Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 June 2012 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
CZChunzhi Zhang
Chunzhi Zhang
JZJunxi Zhang
Junxi Zhang
JHJianwei Hao
Jianwei Hao
ZSZhendong Shi
Zhendong Shi
YWYingyi Wang
Yingyi Wang
CKChunsheng Kang
Chunsheng Kang
Background: MiR-221 and miR-222 (miR-221/222), upregulated in gliomas, can regulate glioma cell cycle progression and apoptosis, respectively. However, the association of miR-221/222 with glioma cell invasion and survival remains unknown. Methods: Invasion capability of miR-221/222 was detected by mutiple analyses, including diffusion tensor imaging (DTI), transwell, wound healing and nude mouse tumor xenograft model assay. Further, the target of miR-221/222 was determined by luciferase reporter, western blot and gene rescue assay. The association of miR-221/222 with outcome was examined in fifty glioma patients. Results: MiR-221/222 expression was significantly increased in high-grade gliomas compared with low-grade gliomas, and positively correlated with the degree of glioma infiltration. Over-expression of miR-221/222 increased cell invasion, whereas knockdown of miR-221/222 decreased cell invasion via modulating the levels of the target, TIMP3. Introduction of a TIMP3 cDNA lacking 3’ UTR abrogated miR-221/222-induced cell invasion. In addition, knockdown of miR-221/222 increased TIMP3 expression and considerably inhibited tumor growth in a xenograft model. Finally, the increased level of miR-221/222 expression in high-grade gliomas confers poorer overall survival. Conclusions: The present data indicate that miR-221 and miR-222 directly regulate cell invasion by targeting TIMP3 and act as prognostic factors for glioma patients.

24 June 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
QDQingsheng Dong
Qingsheng Dong
NCNing Cai
Ning Cai
TTTao Tao
Tao Tao
RZRui Zhang
Rui Zhang
WYWei Yan
Wei Yan
NLNing Liu
Ning Liu
Glioblastoma is an extraordinarily aggressive disease that requires more effective therapeutic options. Snail family zinc finger 1, dysregulated in many neoplasms, has been reported to be involved in gliomas. However, the biological mechanisms underlying SNAI1 function in gliomas need further investigation. Quantitative real-time PCR was used to measure microRNA-128 (miR-128) expression level and western blot was performed to detect protein expression in U87 and U251 cells and human brain tissues. Cell cycle, CCK-8, transwell and wound-healing assays were performed. Dual-luciferase reporter assay was used for identifying the mechanism of SNAI1 and miR-128b regulation. The mechanism of miR-128 targeting SP1 was also tested by luciferase reporter assay. Immunohistochemistry and in situ hybridisation staining were used for quantifying SNAI1, SP1 and miR-128 expression levels in human glioma samples. The Chinese Glioma Genome Atlas (CGGA) data revealed that SNAI1 was up-regulated in glioma and we confirmed the findings in normal and glioma tissues. SNAI1 depletion by shRNA retarded the cell cycle and suppressed proliferation and invasion in glioma cell lines. The CGGA data showed that the Pearson correlation index between SNAI1 and miR-128 was negatively correlated. SNAI1 suppressed miR-128b expression by binding to the miR-128b specific promoter motif, and miR-128 targeted SP1 via binding to the 3′-untranslated region of SP1. Moreover, introduction of miR-128 anti-sense oligonucleotide alleviated the cell cycle retardation, proliferation and invasion inhibition induced by SNAI1 shRNA. Immunohistochemistry and in situ hybridisation analysis of SNAI1, SP1 and miR-128 unraveled their expression levels and correlations in glioma samples. We propose that the SNAI1/miR-128/SP1 axis, which plays a vital role in glioma progression, may come to be a clinically relevant therapeutic target.

14 December 2022 in Oncogene
Verified
Journal Article
Closed access
PDF file
TYTianfu Yu
Tianfu Yu
FZFengqi Zhou
Fengqi Zhou
WTWei Tian
Wei Tian
RXRan Xu
Ran Xu
BWBinbin Wang
Binbin Wang
JZJunxi Zhang
Junxi Zhang

27 May 2015 in Cellular and Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
YZYaxuan Zhang
Yaxuan Zhang
DHDongfeng Han
Dongfeng Han
WWWenjin Wei
Wenjin Wei
WCWenping Cao
Wenping Cao
RZRui Zhang
Rui Zhang
NLNing Liu
Ning Liu

10 June 2014 in Tumor Biology
Verified
Journal Article
Closed access
PDF file
C(Chinese Glioma Cooperative Group (CGCG)
Chinese Glioma Cooperative Group (CGCG)
TTTao Tao
Tao Tao
YSYan Shi
Yan Shi
DHDongfeng Han
Dongfeng Han
WLWenkang Luan
Wenkang Luan
YYYongping You
Yongping You

24 October 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
TZTongle Zhi
Tongle Zhi
TYTianfu Yu
Tianfu Yu
MPMinhong Pan
Minhong Pan
ENEr Nie
Er Nie
WWWeining Wu
Weining Wu
JZJunxi Zhang
Junxi Zhang
EZH2 alteration driven by microRNA-524-5p and microRNA-324-5p promotes cell proliferation and temozolomide resistance in glioma EZH2 alteration driven by microRNA-524-5p and microRNA-324-5p promotes cell proliferation and temozolomide resistance in glioma